|
US4077407A
(en)
*
|
1975-11-24 |
1978-03-07 |
Alza Corporation |
Osmotic devices having composite walls
|
|
US4445885A
(en)
*
|
1977-02-16 |
1984-05-01 |
Unitika, Ltd. |
Insulin releasing supplier
|
|
US4519909A
(en)
*
|
1977-07-11 |
1985-05-28 |
Akzona Incorporated |
Microporous products
|
|
US4159720A
(en)
*
|
1977-11-28 |
1979-07-03 |
Burton Andrew F |
Infusion of liquids into tissue
|
|
US4304672A
(en)
*
|
1978-04-04 |
1981-12-08 |
Sbr Lab, Inc. |
Stored blood and liquid system pH control method and apparatus
|
|
NZ192673A
(en)
*
|
1979-02-02 |
1984-07-06 |
Merck & Co Inc |
Ophthalmic compositions for lowering intraocular pressure
|
|
US4235236A
(en)
*
|
1979-02-12 |
1980-11-25 |
Alza Corporation |
Device for dispensing drug by combined diffusional and osmotic operations
|
|
US4357236A
(en)
*
|
1979-05-17 |
1982-11-02 |
Borg-Warner Corporation |
Automatic addition of a corrosion inhibitor to a coolant system by osmotic pressure
|
|
DE3068986D1
(en)
*
|
1980-01-28 |
1984-09-27 |
Merck & Co Inc |
Ophthalmic inserts for lowering intraocular pressure comprising carbonic anhydrase inhibitors
|
|
IE50901B1
(en)
*
|
1980-03-04 |
1986-08-06 |
Merck & Co Inc |
Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure
|
|
JPS57140710A
(en)
*
|
1981-02-24 |
1982-08-31 |
Shionogi & Co Ltd |
Capsule agent for rectal administration
|
|
JPH0245604B2
(GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
*
|
1980-07-09 |
1990-10-11 |
Yunibaashitei Obu Furorida Za |
|
|
US4300558A
(en)
*
|
1980-07-18 |
1981-11-17 |
Alza Corporation |
Self-driven fluid dispenser
|
|
US4439195A
(en)
*
|
1980-10-14 |
1984-03-27 |
Alza Corporation |
Theophylline therapy
|
|
US4364385A
(en)
*
|
1981-03-13 |
1982-12-21 |
Lossef Steven V |
Insulin delivery device
|
|
USD271623S
(en)
|
1981-04-27 |
1983-11-29 |
Eli Lilly And Company |
Animal capsule
|
|
US4484921A
(en)
*
|
1982-02-01 |
1984-11-27 |
Alza Corporation |
Theophylline therapy utilizing osmotic delivery
|
|
JPS5931701A
(ja)
*
|
1982-08-16 |
1984-02-20 |
Nitto Electric Ind Co Ltd |
液状活性物質含有膜及びその製造方法
|
|
US4443428A
(en)
*
|
1982-06-21 |
1984-04-17 |
Euroceltique, S.A. |
Extended action controlled release compositions
|
|
US4478596A
(en)
*
|
1982-11-26 |
1984-10-23 |
Michelson Paul E |
Delivery system for physiologically active agents
|
|
US4613330A
(en)
*
|
1982-11-26 |
1986-09-23 |
Michelson Paul E |
Delivery system for desired agents
|
|
IE53703B1
(en)
*
|
1982-12-13 |
1989-01-18 |
Elan Corp Plc |
Drug delivery device
|
|
US4585792A
(en)
*
|
1983-05-05 |
1986-04-29 |
Technology Unlimited Inc. |
Protective additive to vaginal products and catamenials
|
|
US4722936A
(en)
*
|
1983-05-05 |
1988-02-02 |
Joseph Jacob |
Deodorization vaginal products and catamenials
|
|
US4722937A
(en)
*
|
1984-06-29 |
1988-02-02 |
Joseph Jacob |
Antitoxin vaginal products and catamenials
|
|
US4765989A
(en)
*
|
1983-05-11 |
1988-08-23 |
Alza Corporation |
Osmotic device for administering certain drugs
|
|
US4783337A
(en)
*
|
1983-05-11 |
1988-11-08 |
Alza Corporation |
Osmotic system comprising plurality of members for dispensing drug
|
|
US5082668A
(en)
*
|
1983-05-11 |
1992-01-21 |
Alza Corporation |
Controlled-release system with constant pushing source
|
|
US4503030A
(en)
*
|
1983-06-06 |
1985-03-05 |
Alza Corporation |
Device for delivering drug to certain pH environments
|
|
US4627850A
(en)
*
|
1983-11-02 |
1986-12-09 |
Alza Corporation |
Osmotic capsule
|
|
US4777049A
(en)
*
|
1983-12-01 |
1988-10-11 |
Alza Corporation |
Constant release system with pulsed release
|
|
US4751071A
(en)
*
|
1983-12-01 |
1988-06-14 |
Alza Corporation |
Composition comprising salbutamol
|
|
US4851229A
(en)
*
|
1983-12-01 |
1989-07-25 |
Alza Corporation |
Composition comprising a therapeutic agent and a modulating agent
|
|
GB2150830B
(en)
*
|
1983-12-05 |
1987-08-19 |
Alza Corp |
Drug dispenser
|
|
US4761159A
(en)
*
|
1984-01-23 |
1988-08-02 |
Lewis Knox |
Method of chemical deodorization of articles and solutions used in medical and biological procedures
|
|
US4729793A
(en)
*
|
1985-08-09 |
1988-03-08 |
Alza Corporation |
Composition for manufacturing wall of dispensing device
|
|
US4814180A
(en)
*
|
1984-03-21 |
1989-03-21 |
Alza Corporation |
Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container
|
|
US4800056A
(en)
*
|
1984-03-21 |
1989-01-24 |
Alza Corporation |
Process for making dispenser with cooperating elements
|
|
US4692326A
(en)
*
|
1984-03-21 |
1987-09-08 |
Alza Corporation |
Dispenser comprising inner positioned soft or hard capsule
|
|
US4663148A
(en)
*
|
1984-03-21 |
1987-05-05 |
Alza Corporation |
Dispenser comprising telescopically engaging members
|
|
US4716031A
(en)
*
|
1984-03-21 |
1987-12-29 |
Alza Corporation |
Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug
|
|
US4663149A
(en)
*
|
1984-03-21 |
1987-05-05 |
Alza Corporation |
Dispenser comprising inner and outer walls functioning as cooperative unit
|
|
US4615698A
(en)
*
|
1984-03-23 |
1986-10-07 |
Alza Corporation |
Total agent osmotic delivery system
|
|
US4649075A
(en)
*
|
1984-08-09 |
1987-03-10 |
Leonora Jost |
Transdermal and transmucosal vortexed foam devices and the method of making
|
|
US4743247A
(en)
*
|
1984-08-13 |
1988-05-10 |
Alza Corporation |
Process for manufacturing dosage form
|
|
GB8422876D0
(en)
*
|
1984-09-11 |
1984-10-17 |
Secr Defence |
Silicon implant devices
|
|
US4693886A
(en)
*
|
1985-04-22 |
1987-09-15 |
Alza Corporation |
Osmotic device with inert core
|
|
US4609374A
(en)
*
|
1985-04-22 |
1986-09-02 |
Alza Corporation |
Osmotic device comprising means for governing initial time of agent release therefrom
|
|
US4655766A
(en)
*
|
1985-08-01 |
1987-04-07 |
Alza Corporation |
Fluid imbibing pump with self-regulating skin patch
|
|
US4756314A
(en)
*
|
1985-10-28 |
1988-07-12 |
Alza Corporation |
Sweat collection patch
|
|
US5204339A
(en)
*
|
1986-01-31 |
1993-04-20 |
Whitby Research, Inc. |
Penetration enhancers for transdermal delivery of systemic agents
|
|
US4886545A
(en)
*
|
1986-01-31 |
1989-12-12 |
Nelson Research & Development Company |
Compositions comprising 1-substituted azacycloalkanes and their uses
|
|
US4867969A
(en)
*
|
1986-02-07 |
1989-09-19 |
Alza Corporation |
Hydrogel formulation for administering non-steroidal drugs
|
|
US4747847A
(en)
*
|
1986-02-07 |
1988-05-31 |
Alza Corporation |
System for delivering potassium chloride with enhanced bioacceptability
|
|
US4971790A
(en)
*
|
1986-02-07 |
1990-11-20 |
Alza Corporation |
Dosage form for lessening irritation of mocusa
|
|
US4786500A
(en)
*
|
1986-06-26 |
1988-11-22 |
Alza Corporation |
Programmable agent delivery system
|
|
US4927632A
(en)
*
|
1986-06-26 |
1990-05-22 |
Alza Corporation |
Selective pulsed drug delivery system
|
|
US4885868A
(en)
*
|
1986-12-03 |
1989-12-12 |
Cornell Research Foundation, Inc. |
Banding techniques for plant propagation
|
|
US4917688A
(en)
*
|
1987-01-14 |
1990-04-17 |
Nelson Research & Development Co. |
Bandage for transdermal delivery of systemically-active drug
|
|
US4832690A
(en)
*
|
1987-01-23 |
1989-05-23 |
Baxter International Inc. |
Needle-pierceable cartridge for drug delivery
|
|
US4801461A
(en)
*
|
1987-01-28 |
1989-01-31 |
Alza Corporation |
Pseudoephedrine dosage form
|
|
US4915952A
(en)
*
|
1987-02-27 |
1990-04-10 |
Alza Corporation |
Composition comprising drug, HPC, HPMC and PEO
|
|
US5023076A
(en)
*
|
1987-02-27 |
1991-06-11 |
Alza Corporation |
Lamina comprising carboxyvinyl polymer
|
|
US4731122A
(en)
*
|
1987-03-30 |
1988-03-15 |
Alza Corporation |
Process for manufacturing a thermoplastic molding composition
|
|
US5340590A
(en)
*
|
1987-06-25 |
1994-08-23 |
Alza Corporation |
Delivery system with bilayer osmotic engine
|
|
US5391381A
(en)
*
|
1987-06-25 |
1995-02-21 |
Alza Corporation |
Dispenser capable of delivering plurality of drug units
|
|
US5236689A
(en)
*
|
1987-06-25 |
1993-08-17 |
Alza Corporation |
Multi-unit delivery system
|
|
US4795641A
(en)
*
|
1987-08-20 |
1989-01-03 |
Eastman Kodak Company |
Polymer blends having reverse phase morphology for controlled delivery of bioactive agents
|
|
US4920101A
(en)
*
|
1987-09-30 |
1990-04-24 |
Nelson Research & Development Co. |
Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloaklkanes
|
|
US4879275A
(en)
*
|
1987-09-30 |
1989-11-07 |
Nelson Research & Development Co. |
Penetration enhancers for transdermal delivery of systemic agent
|
|
US4906475A
(en)
*
|
1988-02-16 |
1990-03-06 |
Paco Pharmaceutical Services |
Estradiol transdermal delivery system
|
|
US4877618A
(en)
*
|
1988-03-18 |
1989-10-31 |
Reed Jr Fred D |
Transdermal drug delivery device
|
|
US4996060A
(en)
*
|
1988-03-25 |
1991-02-26 |
Alza Corporation |
Device comprising liner for protecting fluid sensitive medicament
|
|
US4855141A
(en)
*
|
1988-03-25 |
1989-08-08 |
Alza Corporation |
Device comprising means for protecting and dispensing fluid sensitive medicament
|
|
US4959218A
(en)
*
|
1988-03-25 |
1990-09-25 |
Alza Corporation |
Method for delivering somatotropin to an animal
|
|
US5024842A
(en)
*
|
1988-04-28 |
1991-06-18 |
Alza Corporation |
Annealed coats
|
|
US5160743A
(en)
*
|
1988-04-28 |
1992-11-03 |
Alza Corporation |
Annealed composition for pharmaceutically acceptable drug
|
|
US5006346A
(en)
*
|
1988-04-28 |
1991-04-09 |
Alza Corporation |
Delivery system
|
|
US4931285A
(en)
*
|
1988-04-28 |
1990-06-05 |
Alza Corporation |
Aqueous based pharmaceutical coating composition for dosage forms
|
|
GB8820353D0
(en)
*
|
1988-08-26 |
1988-09-28 |
Staniforth J N |
Controlled release tablet
|
|
US5612059A
(en)
*
|
1988-08-30 |
1997-03-18 |
Pfizer Inc. |
Use of asymmetric membranes in delivery devices
|
|
US5110596A
(en)
*
|
1988-12-13 |
1992-05-05 |
Alza Corporation |
Delivery system comprising means for delivering agent to livestock
|
|
US5037420A
(en)
*
|
1988-12-13 |
1991-08-06 |
Alza Corporation |
Delivery system comprising two sections for delivering somatotropin
|
|
US5057318A
(en)
*
|
1988-12-13 |
1991-10-15 |
Alza Corporation |
Delivery system for beneficial agent over a broad range of rates
|
|
US5174999A
(en)
*
|
1988-12-13 |
1992-12-29 |
Alza Corporation |
Delivery system comprising fluid ingress and drug egress
|
|
US5728088A
(en)
*
|
1988-12-13 |
1998-03-17 |
Alza Corporation |
Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
|
|
US5059423A
(en)
*
|
1988-12-13 |
1991-10-22 |
Alza Corporation |
Delivery system comprising biocompatible beneficial agent formulation
|
|
US5135523A
(en)
*
|
1988-12-13 |
1992-08-04 |
Alza Corporation |
Delivery system for administering agent to ruminants and swine
|
|
US5034229A
(en)
|
1988-12-13 |
1991-07-23 |
Alza Corporation |
Dispenser for increasing feed conversion of hog
|
|
US5030452A
(en)
*
|
1989-01-12 |
1991-07-09 |
Pfizer Inc. |
Dispensing devices powered by lyotropic liquid crystals
|
|
US5108756A
(en)
*
|
1989-01-12 |
1992-04-28 |
Pfizer Inc. |
Dispensing devices powered by lyotropic liquid crystals
|
|
IL92966A
(en)
*
|
1989-01-12 |
1995-07-31 |
Pfizer |
Dispensing devices powered by hydrogel
|
|
US5019396A
(en)
*
|
1989-05-12 |
1991-05-28 |
Alza Corporation |
Delivery dispenser for treating cardiac arrhythmias
|
|
US5126142A
(en)
*
|
1989-07-18 |
1992-06-30 |
Alza Corporation |
Dispenser comprising ionophore
|
|
US5273752A
(en)
*
|
1989-07-18 |
1993-12-28 |
Alza Corporation |
Controlled release dispenser comprising beneficial agent
|
|
US5035897A
(en)
*
|
1989-09-05 |
1991-07-30 |
Alza Corporation |
Dosage form for delivering soluble or insoluble drugs
|
|
US6361795B1
(en)
*
|
1989-09-05 |
2002-03-26 |
Alza Corporation |
Method for lowering blood glucose
|
|
US5112614A
(en)
*
|
1989-09-14 |
1992-05-12 |
Alza Corporation |
Implantable delivery dispenser
|
|
US5098714A
(en)
*
|
1989-11-16 |
1992-03-24 |
Alza Corporation |
Osmotic, oral dosage form for fertility control
|
|
US5200197A
(en)
*
|
1989-11-16 |
1993-04-06 |
Alza Corporation |
Contraceptive pill
|
|
US5223266A
(en)
*
|
1990-01-24 |
1993-06-29 |
Alza Corporation |
Long-term delivery device with early startup
|
|
US5474785A
(en)
*
|
1990-01-24 |
1995-12-12 |
Alza Corporation |
Delivery system comprising means for controlling internal pressure
|
|
US5221536A
(en)
|
1990-05-07 |
1993-06-22 |
Alza Corporation |
Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
|
|
US5190763A
(en)
*
|
1990-05-07 |
1993-03-02 |
Alza Corporation |
Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
|
|
US5192550A
(en)
*
|
1990-05-07 |
1993-03-09 |
Alza Corporation |
Dosage form for treating central nervous system disorders
|
|
US5234692A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
|
US5234694A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Method for increasing feed efficiency in animals
|
|
US5234693A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
|
US5180591A
(en)
*
|
1990-07-11 |
1993-01-19 |
Alza Corporation |
Delivery device with a protective sleeve
|
|
US5238687A
(en)
*
|
1990-07-11 |
1993-08-24 |
Alza Corporation |
Delivery device with a protective sleeve
|
|
ATE118345T1
(de)
*
|
1990-08-07 |
1995-03-15 |
Pfizer |
Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen.
|
|
JP2701977B2
(ja)
*
|
1990-09-28 |
1998-01-21 |
ファイザー インク |
疎水性媒体を含有する投薬体
|
|
US5378475A
(en)
*
|
1991-02-21 |
1995-01-03 |
University Of Kentucky Research Foundation |
Sustained release drug delivery devices
|
|
US6764697B1
(en)
|
1991-06-27 |
2004-07-20 |
Alza Corporation |
System for delaying drug delivery up to seven hours
|
|
US5178867A
(en)
*
|
1991-08-19 |
1993-01-12 |
Alza Corporation |
Dosage form for delivering drug in short-time period
|
|
US5240713A
(en)
*
|
1991-09-27 |
1993-08-31 |
Alza Corporation |
Dual rate agent delivery device
|
|
US5200195A
(en)
*
|
1991-12-06 |
1993-04-06 |
Alza Corporation |
Process for improving dosage form delivery kinetics
|
|
US5254349A
(en)
*
|
1991-12-06 |
1993-10-19 |
Alza Corporation |
Process for lessening irritation caused by drug
|
|
US5266332A
(en)
*
|
1991-12-06 |
1993-11-30 |
Alza Corporation |
Method for administering anti-Parkinson drug
|
|
US5200194A
(en)
*
|
1991-12-18 |
1993-04-06 |
Alza Corporation |
Oral osmotic device
|
|
IT1255522B
(it)
*
|
1992-09-24 |
1995-11-09 |
Ubaldo Conte |
Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
|
|
US5358721A
(en)
*
|
1992-12-04 |
1994-10-25 |
Alza Corporation |
Antiviral therapy
|
|
US6440457B1
(en)
*
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
|
US6287598B1
(en)
|
1993-05-28 |
2001-09-11 |
Alza Corporation |
Method for providing sustained antiepileptic therapy
|
|
US6676967B1
(en)
*
|
1993-09-20 |
2004-01-13 |
Kos Pharmaceuticals, Inc. |
Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
|
|
US20060263428A1
(en)
*
|
1993-09-20 |
2006-11-23 |
Eugenio Cefali |
Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
|
|
US6746691B2
(en)
|
1993-09-20 |
2004-06-08 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
|
|
US6129930A
(en)
*
|
1993-09-20 |
2000-10-10 |
Bova; David J. |
Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
|
|
US20080045573A1
(en)
*
|
1993-09-20 |
2008-02-21 |
Bova David J |
Methods and Sustained Release Nicotinic Acid Compositions for Treating Hyperlipidemia
|
|
US6818229B1
(en)
|
1993-09-20 |
2004-11-16 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia
|
|
US6080428A
(en)
*
|
1993-09-20 |
2000-06-27 |
Bova; David J. |
Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
|
|
US6183778B1
(en)
|
1993-09-21 |
2001-02-06 |
Jagotec Ag |
Pharmaceutical tablet capable of liberating one or more drugs at different release rates
|
|
US5532003A
(en)
*
|
1994-01-18 |
1996-07-02 |
Alza Corporation |
Pentoxifylline therapy
|
|
US5773021A
(en)
*
|
1994-03-14 |
1998-06-30 |
Vetoquinol S.A. |
Bioadhesive ophthalmic insert
|
|
US5525279A
(en)
*
|
1994-04-04 |
1996-06-11 |
Sekisui Kagaku Kogyo K.K. |
Method of forming a granulocyte adsorbing carrier and granulocyte remover
|
|
US20040191314A1
(en)
*
|
1994-04-28 |
2004-09-30 |
Frank Jao |
Antiepileptic dosage form and process for protecting antiepileptic drug
|
|
ZA953078B
(en)
*
|
1994-04-28 |
1996-01-05 |
Alza Corp |
Effective therapy for epilepsies
|
|
US5698224A
(en)
*
|
1994-06-27 |
1997-12-16 |
Alza Corporation |
Tacrine therapy
|
|
US5914131A
(en)
*
|
1994-07-07 |
1999-06-22 |
Alza Corporation |
Hydromorphone therapy
|
|
US5595759A
(en)
*
|
1994-11-10 |
1997-01-21 |
Alza Corporation |
Process for providing therapeutic composition
|
|
US5690952A
(en)
*
|
1995-06-07 |
1997-11-25 |
Judy A. Magruder et al. |
Implantable system for delivery of fluid-sensitive agents to animals
|
|
US5713852A
(en)
*
|
1995-06-07 |
1998-02-03 |
Alza Corporation |
Oral dosage and method for treating painful conditions of the oral cavity
|
|
IT1282576B1
(it)
|
1996-02-06 |
1998-03-31 |
Jagotec Ag |
Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
|
|
US7094422B2
(en)
*
|
1996-02-19 |
2006-08-22 |
Acrux Dds Pty Ltd. |
Topical delivery of antifungal agents
|
|
AUPN814496A0
(en)
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
|
IT1282650B1
(it)
*
|
1996-02-19 |
1998-03-31 |
Jagotec Ag |
Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
|
|
DK0914178T3
(da)
|
1996-06-18 |
2003-04-22 |
Alza Corp |
Anordning til forøgelse af transdermal afgivelse eller prøveudtagning af et middel
|
|
US5800624A
(en)
*
|
1996-10-22 |
1998-09-01 |
University Of Notre Dame |
Membrane process for separating carbohydrates
|
|
DE69735002T2
(de)
*
|
1996-10-25 |
2006-10-26 |
Shire Laboratories, Inc. |
Osmotisches Verabreichungssystem für lösliche Dosen
|
|
US6361796B1
(en)
|
1996-10-25 |
2002-03-26 |
Shire Laboratories, Inc. |
Soluble form osmotic dose delivery system
|
|
US6110499A
(en)
*
|
1997-07-24 |
2000-08-29 |
Alza Corporation |
Phenytoin therapy
|
|
US5902598A
(en)
*
|
1997-08-28 |
1999-05-11 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices
|
|
US6514530B2
(en)
|
1997-09-09 |
2003-02-04 |
Alza Corporation |
Dosage form comprising means for changing drug delivery shape
|
|
IN186245B
(GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
|
1997-09-19 |
2001-07-14 |
Ranbaxy Lab Ltd |
|
|
US20040062799A1
(en)
*
|
1997-09-29 |
2004-04-01 |
Ayer Atul D. |
Therapeutic composition and delivery system for administering drug
|
|
PT1035834E
(pt)
|
1997-12-05 |
2002-09-30 |
Alza Corp |
Forma de dosagem osmotica que compreende primeiro e segundo revestimentos
|
|
TR200001828T2
(tr)
*
|
1997-12-22 |
2000-11-21 |
Euro-Celtique, S.A. |
Opioid dozaj şekillerinin kötüye kullanımını önlemeye yönelik bir yöntem.
|
|
AU1623099A
(en)
*
|
1997-12-22 |
1999-07-12 |
Alza Corporation |
Rate controlling membranes for controlled drug delivery devices
|
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
|
ES2415876T3
(es)
*
|
1997-12-22 |
2013-07-29 |
Euro-Celtique S.A. |
Forma de dosificación farmacéutica oral que comprende una combinación de un agonista de opiáceos y un antagonista de opiáceos
|
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
|
US8524277B2
(en)
*
|
1998-03-06 |
2013-09-03 |
Alza Corporation |
Extended release dosage form
|
|
US6099859A
(en)
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
|
US20010038855A1
(en)
*
|
1998-06-05 |
2001-11-08 |
Desjardin Michael A. |
Dosage form for administering prescribed dose
|
|
US6099862A
(en)
*
|
1998-08-31 |
2000-08-08 |
Andrx Corporation |
Oral dosage form for the controlled release of a biguanide and sulfonylurea
|
|
US6551613B1
(en)
*
|
1998-09-08 |
2003-04-22 |
Alza Corporation |
Dosage form comprising therapeutic formulation
|
|
US6174547B1
(en)
*
|
1999-07-14 |
2001-01-16 |
Alza Corporation |
Dosage form comprising liquid formulation
|
|
GB9822854D0
(en)
|
1998-10-21 |
1998-12-16 |
Reckitt & Colmann Prod Ltd |
Improvements in or relating to organic compositions
|
|
US6706282B1
(en)
|
1998-11-02 |
2004-03-16 |
Evangeline Cruz |
Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
|
|
AU1238500A
(en)
*
|
1998-11-02 |
2000-05-22 |
Alza Corporation |
Controlled delivery of active agents
|
|
US6342249B1
(en)
|
1998-12-23 |
2002-01-29 |
Alza Corporation |
Controlled release liquid active agent formulation dosage forms
|
|
EP1152709B1
(en)
*
|
1999-02-02 |
2005-01-12 |
Wright Medical Technology, Inc. |
Controlled release composite
|
|
US6217895B1
(en)
*
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
US6319510B1
(en)
|
1999-04-20 |
2001-11-20 |
Alayne Yates |
Gum pad for delivery of medication to mucosal tissues
|
|
CO5210862A1
(es)
|
1999-09-15 |
2002-10-30 |
Alza Corp |
Formas de dosificacion y metodos para proporcionar efectiva terapia de reboxetina con dosificacion de una vez al dia
|
|
KR100738276B1
(ko)
*
|
1999-12-09 |
2007-07-12 |
알자 코포레이션 |
항바이러스성 약제
|
|
US6464688B1
(en)
|
2000-02-15 |
2002-10-15 |
Microsolutions, Inc. |
Osmotic pump delivery system with flexible drug compartment
|
|
AR030557A1
(es)
*
|
2000-04-14 |
2003-08-27 |
Jagotec Ag |
Una tableta en multicapa de liberacion controlada y metodo de tratamiento
|
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
|
USRE44145E1
(en)
|
2000-07-07 |
2013-04-09 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
|
|
RU2253452C2
(ru)
|
2000-10-30 |
2005-06-10 |
Эро-Селтик С.А. |
Композиции гидрокодона с контролируемым высвобождением
|
|
MXPA03003994A
(es)
|
2000-11-03 |
2004-09-10 |
Andrx Labs Llc |
Composiciones de metformina de liberacion controlada.
|
|
US20060034922A1
(en)
*
|
2000-11-03 |
2006-02-16 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
|
US6790459B1
(en)
|
2000-11-03 |
2004-09-14 |
Andrx Labs, Llc |
Methods for treating diabetes via administration of controlled release metformin
|
|
US6866866B1
(en)
*
|
2000-11-03 |
2005-03-15 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
|
US6632217B2
(en)
|
2001-04-19 |
2003-10-14 |
Microsolutions, Inc. |
Implantable osmotic pump
|
|
US20050215727A1
(en)
|
2001-05-01 |
2005-09-29 |
Corium |
Water-absorbent adhesive compositions and associated methods of manufacture and use
|
|
US8840918B2
(en)
|
2001-05-01 |
2014-09-23 |
A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences |
Hydrogel compositions for tooth whitening
|
|
RU2286801C2
(ru)
|
2001-05-01 |
2006-11-10 |
Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук |
Двухфазные биоадгезионные композиции, абсорбирующие воду
|
|
US20050113510A1
(en)
|
2001-05-01 |
2005-05-26 |
Feldstein Mikhail M. |
Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
|
|
AU2002308612B2
(en)
|
2001-05-01 |
2008-04-10 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions
|
|
US8541021B2
(en)
|
2001-05-01 |
2013-09-24 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions demonstrating phase separation on contact with aqueous media
|
|
US8206738B2
(en)
|
2001-05-01 |
2012-06-26 |
Corium International, Inc. |
Hydrogel compositions with an erodible backing member
|
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
|
CN1525851A
(zh)
|
2001-05-11 |
2004-09-01 |
������ҩ������˾ |
抗滥用阿片样物质控释剂型
|
|
DE60239868D1
(de)
|
2001-06-12 |
2011-06-09 |
Univ Johns Hopkins Med |
Reservoirvorrichtung für die intraokulare arzneimittelabgabe
|
|
AU2002316738B2
(en)
|
2001-07-18 |
2009-01-08 |
Euro-Celtique S.A. |
Pharmaceutical combinations of oxycodone and naloxone
|
|
AU2002324624A1
(en)
|
2001-08-06 |
2003-02-24 |
Euro-Celtique S.A. |
Sequestered antagonist formulations
|
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
|
EP1429745A2
(en)
*
|
2001-09-28 |
2004-06-23 |
McNEIL-PPC, INC. |
Composite dosage forms having an inlaid portion
|
|
US8101209B2
(en)
*
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
|
WO2003051341A1
(en)
*
|
2001-12-18 |
2003-06-26 |
Alza Corporation |
Dosage form for providing time-varying patterns of drug delivery
|
|
CA2471096A1
(en)
*
|
2001-12-19 |
2003-07-03 |
Alza Corporation |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
|
KR20040090961A
(ko)
*
|
2001-12-19 |
2004-10-27 |
알자 코포레이션 |
치료제의 조절된 방출을 위한 제제 및 투여 형태
|
|
US20030161882A1
(en)
*
|
2002-02-01 |
2003-08-28 |
Waterman Kenneth C. |
Osmotic delivery system
|
|
TW200302748A
(en)
*
|
2002-02-01 |
2003-08-16 |
Pfizer Prod Inc |
Osmotic delivery system
|
|
US7004171B2
(en)
*
|
2002-02-25 |
2006-02-28 |
Hi-Gienic Intra Vaginal Technologies Ltd. |
System for transvaginal drug delivery
|
|
ITMI20020515A1
(it)
*
|
2002-03-12 |
2003-09-12 |
Jagotec Ag |
Sistema per il rilasco controllato di uno o piu' principi attivi
|
|
ITMI20020514A1
(it)
*
|
2002-03-12 |
2003-09-12 |
Jagotec Ag |
Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
|
|
DE20308437U1
(de)
|
2002-04-05 |
2003-11-13 |
Euroceltique S.A., Luxemburg/Luxembourg |
Matrix zur verzögerten, gleichbleibenden und unabhängigen Freisetzung von Wirkstoffen
|
|
US20050106249A1
(en)
*
|
2002-04-29 |
2005-05-19 |
Stephen Hwang |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
|
CA2483655A1
(en)
*
|
2002-04-29 |
2003-11-13 |
Alza Corporation |
Methods and dosage forms for controlled delivery of oxycodone
|
|
US8871241B2
(en)
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
|
AU2003241537A1
(en)
*
|
2002-05-23 |
2003-12-12 |
Andrx Corporation |
Biguanide formulations
|
|
US20040166159A1
(en)
*
|
2002-05-29 |
2004-08-26 |
Chien-Hsuan Han |
Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa
|
|
US20030224045A1
(en)
*
|
2002-05-29 |
2003-12-04 |
Chien-Hsuan Han |
Combination immediate release sustained release levodopa/carbidopa dosage forms
|
|
US7094427B2
(en)
*
|
2002-05-29 |
2006-08-22 |
Impax Laboratories, Inc. |
Combination immediate release controlled release levodopa/carbidopa dosage forms
|
|
US20060013875A1
(en)
*
|
2002-05-29 |
2006-01-19 |
Impax Laboratories, Inc. |
Combination immediate release controlled release levodopa/carbidopa dosage forms
|
|
CN1671358A
(zh)
*
|
2002-05-31 |
2005-09-21 |
阿尔扎公司 |
用于渗透传递可变剂量的羟考酮的剂型和组合物
|
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
|
IL166023A0
(en)
*
|
2002-06-28 |
2006-01-15 |
Alza Corp |
Oral dosage from comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition
|
|
US20050232995A1
(en)
*
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
|
MXPA05001184A
(es)
*
|
2002-07-29 |
2005-09-12 |
Johnson & Johnson |
Formulaciones y formas de dosificacion para administracion controlada de topiramato.
|
|
US7959946B2
(en)
|
2002-09-20 |
2011-06-14 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
|
US9060941B2
(en)
*
|
2002-09-20 |
2015-06-23 |
Actavis, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
|
US20050051922A1
(en)
*
|
2002-09-20 |
2005-03-10 |
Avinash Nangia |
Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
|
|
US20050048119A1
(en)
*
|
2002-09-20 |
2005-03-03 |
Avinash Nangia |
Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
|
|
CN100544717C
(zh)
|
2002-09-20 |
2009-09-30 |
华生制药公司 |
含有双胍和噻唑烷二酮衍生物的药物剂型
|
|
US7785627B2
(en)
*
|
2002-09-20 |
2010-08-31 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
|
CN1731987A
(zh)
*
|
2002-10-31 |
2006-02-08 |
阿尔扎公司 |
提供液体制剂上升式释放的剂型
|
|
EP1556000A1
(en)
*
|
2002-10-31 |
2005-07-27 |
Alza Corporation |
Pharmaceutical formulation providing an increased biovailability of hydrophobic drugs
|
|
US6893660B2
(en)
*
|
2002-11-21 |
2005-05-17 |
Andrx Pharmaceuticals, Inc. |
Stable pharmaceutical compositions without a stabilizer
|
|
CN1774241B
(zh)
|
2002-12-13 |
2010-05-05 |
杜雷科特公司 |
包含高粘度液体载体材料的口服递药系统
|
|
US7259186B2
(en)
*
|
2002-12-17 |
2007-08-21 |
Abbott Laboratories |
Salts of fenofibric acid and pharmaceutical formulations thereof
|
|
CN100473378C
(zh)
*
|
2002-12-17 |
2009-04-01 |
阿伯特有限及两合公司 |
包含非诺贝酸、其生理可接受的盐或衍生物的制剂
|
|
US20080051411A1
(en)
*
|
2002-12-17 |
2008-02-28 |
Cink Russell D |
Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
|
|
CA2512786A1
(en)
*
|
2003-01-14 |
2004-08-05 |
Alza Corporation |
Methods and dosage forms with modified viscosity layers
|
|
ATE401866T1
(de)
*
|
2003-02-11 |
2008-08-15 |
Alza Corp |
Verfahren und dosierformen mit modifizierter schichtgeometrie
|
|
MY135852A
(en)
*
|
2003-04-21 |
2008-07-31 |
Euro Celtique Sa |
Pharmaceutical products
|
|
US7611480B2
(en)
*
|
2003-04-24 |
2009-11-03 |
Levy Mark M |
Gastrointestinal bioreactor
|
|
EP1643946A2
(en)
*
|
2003-06-20 |
2006-04-12 |
Viral Genomix, Inc. |
Compositions for and methods for treating hiv
|
|
TWI377958B
(en)
|
2003-06-26 |
2012-12-01 |
Control Delivery Sys Inc |
In-situ gelling drug delivery system
|
|
WO2005000268A2
(en)
*
|
2003-06-26 |
2005-01-06 |
Control Delivery Systems, Inc. |
Bioerodible sustained release drug delivery systems
|
|
US8802139B2
(en)
*
|
2003-06-26 |
2014-08-12 |
Intellipharmaceutics Corp. |
Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
|
|
EP1653922A2
(en)
*
|
2003-08-06 |
2006-05-10 |
Alza Corporation |
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
|
|
US20050136108A1
(en)
*
|
2003-08-22 |
2005-06-23 |
Yam Noymi V. |
Stepwise delivery of topiramate over prolonged period of time
|
|
US20050069587A1
(en)
*
|
2003-09-02 |
2005-03-31 |
Modi Nishit Bachulal |
Novel drug compositions and dosage forms of topiramate
|
|
US7611728B2
(en)
*
|
2003-09-05 |
2009-11-03 |
Supernus Pharmaceuticals, Inc. |
Osmotic delivery of therapeutic compounds by solubility enhancement
|
|
PL1663229T3
(pl)
|
2003-09-25 |
2010-09-30 |
Euro Celtique Sa |
Farmaceutyczne kombinacje hydrokodonu i naltreksonu
|
|
KR20060070575A
(ko)
*
|
2003-09-26 |
2006-06-23 |
알자 코포레이션 |
활성성분 제제의 방출제어용 제형
|
|
AU2004275835B2
(en)
|
2003-09-26 |
2011-06-23 |
Alza Corporation |
Controlled release formulations exhibiting an ascending rate of release
|
|
WO2005030164A2
(en)
*
|
2003-09-26 |
2005-04-07 |
Alza Corporation |
Improved controlled release dosage form including a banded engine
|
|
CN1897924B
(zh)
*
|
2003-09-26 |
2011-09-21 |
阿尔扎公司 |
能提供高载药量的药物包衣和提供它的方法
|
|
CA2540050A1
(en)
*
|
2003-09-26 |
2005-04-07 |
Nishit B. Modi |
Osmotic dosage forms for controlled delivery of alprazolam
|
|
MXPA06003454A
(es)
*
|
2003-09-26 |
2006-08-31 |
Johnson & Johnson |
Formulaciones de liberacion controlada de analgesicos opioides y no opiodes.
|
|
DE602004032149D1
(de)
*
|
2003-09-26 |
2011-05-19 |
Alza Corp |
Oros-push-stick für die kontrollierte abgabe von wirkstoffen
|
|
AU2004285531A1
(en)
*
|
2003-10-31 |
2005-05-12 |
Alza Corporation |
Compositions and dosage forms for enhanced absorption of metformin
|
|
US20050095288A1
(en)
*
|
2003-11-03 |
2005-05-05 |
Andrx Labs, Llc |
Decongestant and expectorant tablets
|
|
US20050129765A1
(en)
*
|
2003-11-14 |
2005-06-16 |
Shaoling Li |
Controlled release of topiramate in liquid dosage forms
|
|
US20050175695A1
(en)
*
|
2003-11-25 |
2005-08-11 |
Catherine Castan |
Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
|
|
WO2005051325A2
(en)
*
|
2003-11-25 |
2005-06-09 |
Sb Pharmco Puerto Rico Inc. |
Carvedilol compositions methods of treatment and delivery
|
|
US20050129764A1
(en)
*
|
2003-12-11 |
2005-06-16 |
Vergez Juan A. |
Osmotic device containing licofelone
|
|
EP1703894A1
(en)
*
|
2003-12-23 |
2006-09-27 |
ALZA Corporation |
Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
|
|
WO2005065648A2
(en)
*
|
2003-12-29 |
2005-07-21 |
Alza Corporation, Inc., |
Novel drug compositions and dosage forms of topiramate
|
|
US20050175696A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Drug granule coatings that impart smear resistance during mechanical compression
|
|
WO2005065646A2
(en)
*
|
2003-12-29 |
2005-07-21 |
Alza Corporation, Inc., |
Novel drug compositions and dosage forms
|
|
US8658201B2
(en)
|
2004-01-30 |
2014-02-25 |
Corium International, Inc. |
Rapidly dissolving film for delivery of an active agent
|
|
US20050196442A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
|
US20050196446A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
|
US20050196447A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
|
US20050196448A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Hai Yong Huang |
Polymeric compositions and dosage forms comprising the same
|
|
TWI483944B
(zh)
*
|
2004-03-30 |
2015-05-11 |
Euro Celtique Sa |
含有小於２５ｐｐｍ１４-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
|
|
US20060009425A1
(en)
*
|
2004-05-28 |
2006-01-12 |
Leticia Delgado-Herrera |
Oral formulations of paricalcitol
|
|
EP1604666A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
|
|
EP1604667A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the restless leg syndrome
|
|
WO2005123039A1
(en)
|
2004-06-12 |
2005-12-29 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent drug formulations
|
|
US20050276848A1
(en)
*
|
2004-06-15 |
2005-12-15 |
Nilobon Podhipleux |
Sustained release neutralized divalproex sodium
|
|
US7713550B2
(en)
*
|
2004-06-15 |
2010-05-11 |
Andrx Corporation |
Controlled release sodium valproate formulation
|
|
US20050287185A1
(en)
*
|
2004-06-23 |
2005-12-29 |
David Wong |
Extended release oxybutynin formulation
|
|
WO2006007323A2
(en)
*
|
2004-06-28 |
2006-01-19 |
Alza Corporation |
Dosage forms for low solubility and/or low dissolution rate free acid pharmaceutical agents
|
|
EP1761265A2
(en)
*
|
2004-06-28 |
2007-03-14 |
ALZA Corporation |
A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device
|
|
US20050287214A1
(en)
*
|
2004-06-28 |
2005-12-29 |
Ayer Atul D |
Squeeze controlled oral dosage form
|
|
US8394409B2
(en)
*
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
|
US20060001011A1
(en)
*
|
2004-07-02 |
2006-01-05 |
Wilson Neil R |
Surface conditioner for powder coating systems
|
|
CN101039706A
(zh)
|
2004-08-05 |
2007-09-19 |
考里安国际公司 |
粘合剂组合物
|
|
WO2006023286A2
(en)
*
|
2004-08-19 |
2006-03-02 |
Alza Corporation |
Controlled release nanoparticle active agent formulation dosage forms and methods
|
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
|
ES2617253T3
(es)
|
2004-11-24 |
2017-06-16 |
Meda Pharmaceuticals Inc. |
Composiciones que comprenden azelastina y métodos de uso de las mismas
|
|
US8758816B2
(en)
*
|
2004-11-24 |
2014-06-24 |
Meda Pharmaceuticals Inc. |
Compositions comprising azelastine and methods of use thereof
|
|
US20070020330A1
(en)
*
|
2004-11-24 |
2007-01-25 |
Medpointe Healthcare Inc. |
Compositions comprising azelastine and methods of use thereof
|
|
US8574626B2
(en)
|
2004-12-03 |
2013-11-05 |
Osmotica Kereskedelmi és Szolgáltató KFT |
Osmotic device containing amantadine and an osmotic salt
|
|
AR053986A1
(es)
|
2004-12-03 |
2007-05-30 |
Osmotica Pharmaceutical Argent |
Dispositivo osmotico que contiene amantadina y una sal osmotica
|
|
US8252331B2
(en)
*
|
2004-12-03 |
2012-08-28 |
Osmotica Kereskedelmi és Szolgáltató, KFT |
Osmotic device containing amantadine and an osmotic salt
|
|
WO2006081569A2
(en)
*
|
2005-01-27 |
2006-08-03 |
Alza Corporation |
Oral osmotic dosage form having a high flux membrane
|
|
EP1771160A2
(en)
*
|
2005-01-28 |
2007-04-11 |
Euroceltique S.A. |
Alcohol resistant dosage forms
|
|
EP1702558A1
(en)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Method and device for the assessment of bowel function
|
|
EP1695700A1
(en)
*
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Dosage form containing oxycodone and naloxone
|
|
US7744556B2
(en)
*
|
2005-03-25 |
2010-06-29 |
Kimberly-Clark Worldwide, Inc. |
Delivery tube assembly for an applicator
|
|
US7919453B2
(en)
*
|
2005-03-25 |
2011-04-05 |
Kimberly-Clark Worldwide, Inc. |
Dosage cap assembly for an applicator
|
|
US7993667B2
(en)
*
|
2005-03-25 |
2011-08-09 |
Kimberly-Clark Worldwide, Inc. |
Methods of manufacturing a medicated tampon assembly
|
|
US7527614B2
(en)
|
2005-03-25 |
2009-05-05 |
Kimberly-Clark Worldwide, Inc. |
Protective tube for a medicated tampon
|
|
US9295289B2
(en)
*
|
2005-04-01 |
2016-03-29 |
Leslie Jane James |
Waist-fastening, hip-encompassing apparel with at least one concealed storage compartment
|
|
EA023376B1
(ru)
|
2005-04-08 |
2016-05-31 |
Эббот Лабораториз |
Твердая дозированная форма и содержащая ее упаковка для комбинированной терапии
|
|
US20080152714A1
(en)
*
|
2005-04-08 |
2008-06-26 |
Yi Gao |
Pharmaceutical Formulations
|
|
US20060233882A1
(en)
*
|
2005-04-15 |
2006-10-19 |
Sowden Harry S |
Osmotic dosage form
|
|
JP2008536928A
(ja)
*
|
2005-04-19 |
2008-09-11 |
アルザ・コーポレーシヨン |
トラマドール及び、ガバペンチンを含んでなる物質、の組み合わせ物
|
|
US7708726B2
(en)
*
|
2005-04-28 |
2010-05-04 |
Kimberly-Clark Worldwide, Inc. |
Dosage form cap for an applicator
|
|
EP1896002A4
(en)
|
2005-06-27 |
2009-11-25 |
Biovail Lab Int Srl |
BUPROPIONAL SALT FORMULATIONS WITH MODIFIED RELEASE
|
|
JP2009500339A
(ja)
*
|
2005-06-29 |
2009-01-08 |
アルザ・コーポレーシヨン |
浸透性剤形のための低下された乾燥時間を提供する半透過性組成物
|
|
EP1912622A2
(en)
*
|
2005-08-04 |
2008-04-23 |
Alza Corporation |
Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties
|
|
US20070036929A1
(en)
*
|
2005-08-09 |
2007-02-15 |
The Boeing Company |
Thin film applique
|
|
RU2433821C2
(ru)
*
|
2005-08-30 |
2011-11-20 |
Пирамал Лайф Сайнсис Лимитед |
Фармацевтическая композиция метформина с длительным высвобождением и способ ее получения
|
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
|
US8182841B2
(en)
*
|
2005-09-27 |
2012-05-22 |
Tissue Tech, Inc. |
Amniotic membrane preparations and purified compositions and anti-inflammation methods
|
|
US8187639B2
(en)
|
2005-09-27 |
2012-05-29 |
Tissue Tech, Inc. |
Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
|
|
US20070190137A1
(en)
*
|
2005-10-07 |
2007-08-16 |
Reyes Iran |
Osmotic dosage form with controlled release and fast release aspects
|
|
US20070092559A1
(en)
*
|
2005-10-24 |
2007-04-26 |
Jinghua Yuan |
Liquid dosage forms having enteric properties of delayed and then sustained release
|
|
PL116330U1
(en)
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
|
ES2812250T3
(es)
|
2005-11-28 |
2021-03-16 |
Marinus Pharmaceuticals Inc |
Formulaciones de ganaxolona y procedimientos para la preparación y uso de las mismas
|
|
US20070141118A1
(en)
*
|
2005-12-15 |
2007-06-21 |
Damico Joyce A |
Layered dosage form for a medicated tampon assembly
|
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
EP1813276A1
(en)
*
|
2006-01-27 |
2007-08-01 |
Euro-Celtique S.A. |
Tamper resistant dosage forms
|
|
US20070196487A1
(en)
*
|
2006-02-16 |
2007-08-23 |
Geerke Johan H |
Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
|
|
JP2009531314A
(ja)
|
2006-03-10 |
2009-09-03 |
ニューロジェン・コーポレーション |
ピペラジニルオキソアルキルテトラヒドロイソキノリン類および関連類似物
|
|
CN104825397A
(zh)
*
|
2006-04-03 |
2015-08-12 |
伊萨·奥迪迪 |
含有机溶胶涂层的受控释放递送物件
|
|
CN101453996B
(zh)
*
|
2006-04-03 |
2016-05-11 |
伊萨·奥迪迪 |
药物递送组合物
|
|
US8747897B2
(en)
|
2006-04-27 |
2014-06-10 |
Supernus Pharmaceuticals, Inc. |
Osmotic drug delivery system
|
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
|
US20080090897A1
(en)
|
2006-08-11 |
2008-04-17 |
The Johns Hopkins University |
Compositions and methods for neuroprotectin
|
|
US7538652B2
(en)
*
|
2006-08-29 |
2009-05-26 |
International Business Machines Corporation |
Electrical component tuned by conductive layer deletion
|
|
EP1897543A1
(en)
|
2006-08-30 |
2008-03-12 |
Euro-Celtique S.A. |
Buprenorphine- wafer for drug substitution therapy
|
|
SI2529621T1
(sl)
|
2006-09-22 |
2017-04-26 |
Pharmacyclics Llc |
Inhibitorji Bruton tirozin kinaze
|
|
EP2591675A1
(en)
|
2006-11-27 |
2013-05-15 |
H. Lundbeck A/S |
Heteroaryl amide derivatives
|
|
CA2669815A1
(en)
|
2006-11-28 |
2008-06-05 |
Marinus Pharmaceuticals |
Nanoparticulate formulations and methods for the making and use thereof
|
|
WO2008084698A1
(ja)
|
2006-12-28 |
2008-07-17 |
Astellas Pharma Inc. |
タクロリムス徐放性医薬組成物
|
|
US8524749B2
(en)
*
|
2007-02-09 |
2013-09-03 |
Alza Corporation |
Controlled release compositions of tizanidine
|
|
MX2009006114A
(es)
*
|
2007-03-02 |
2009-11-10 |
Meda Pharmaceuticals Inc |
Composiciones que comprenden carisoprodol y metodos de uso de las mismas.
|
|
US20070172525A1
(en)
*
|
2007-03-15 |
2007-07-26 |
Ramesh Sesha |
Anti-diabetic combinations
|
|
US20080064701A1
(en)
*
|
2007-04-24 |
2008-03-13 |
Ramesh Sesha |
Anti-diabetic combinations
|
|
US8940326B2
(en)
|
2007-03-19 |
2015-01-27 |
Vita Sciences Llc |
Transdermal patch and method for delivery of vitamin B12
|
|
US20090082315A1
(en)
*
|
2007-09-05 |
2009-03-26 |
Raif Tawakol |
Compositions and Methods for Controlling Cholesterol Levels
|
|
CN101854933A
(zh)
|
2007-09-10 |
2010-10-06 |
钙医学公司 |
调节细胞内钙的化合物
|
|
US20090087484A1
(en)
*
|
2007-09-28 |
2009-04-02 |
Alza Corporation |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
|
SI2596784T1
(sl)
|
2007-11-23 |
2017-04-26 |
Gruenenthal Gmbh |
Sestavki tapentadola
|
|
EP2067471B1
(en)
|
2007-12-06 |
2018-02-14 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
|
JP2011511782A
(ja)
|
2008-02-12 |
2011-04-14 |
アボット・ラボラトリーズ |
長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
|
|
US8551524B2
(en)
*
|
2008-03-14 |
2013-10-08 |
Iycus, Llc |
Anti-diabetic combinations
|
|
CN102027133A
(zh)
*
|
2008-05-07 |
2011-04-20 |
温瑟瑞克斯有限公司 |
鉴定调节癌细胞中Wnt信号传导的化合物的方法
|
|
WO2009137631A2
(en)
*
|
2008-05-07 |
2009-11-12 |
Wintherix Llc |
Methods for identifying compounds that affect expression of cancer-related protein isoforms
|
|
NZ588311A
(en)
*
|
2008-07-24 |
2012-08-31 |
Handa Pharmaceuticals Llc |
Stabilized atypical antipsychotic formulation to treat psychiatric conditions
|
|
RU2472791C2
(ru)
|
2008-08-27 |
2013-01-20 |
КалсиМедика Инк. |
Соединения, модулирующие внутриклеточный кальций
|
|
US20100190752A1
(en)
|
2008-09-05 |
2010-07-29 |
Gruenenthal Gmbh |
Pharmaceutical Combination
|
|
EP2163240A1
(en)
|
2008-09-12 |
2010-03-17 |
Universita' Degli Studi Di Genova |
A method for the production of bioadhesive compact matrices
|
|
SI2352494T1
(sl)
|
2008-10-30 |
2019-12-31 |
Gruenenthal Gmbh |
Nove in potentne dozirne oblike tapentadola
|
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
|
US20100233259A1
(en)
*
|
2008-12-12 |
2010-09-16 |
Pascal Grenier |
Dosage form of ropinirole
|
|
US20100158905A1
(en)
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Combination therapy of arthritis with tranilast
|
|
EP2387394B1
(en)
|
2009-01-14 |
2018-05-02 |
Corium International, Inc. |
Transdermal administration of tamsulosin
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
CN102365109B
(zh)
*
|
2009-01-29 |
2015-06-03 |
弗赛特影像4股份有限公司 |
后段给药
|
|
US20100209489A1
(en)
*
|
2009-02-04 |
2010-08-19 |
Supernus Pharmaceuticals, Inc. |
Formulations of desvenlafaxine
|
|
DK3045043T3
(da)
|
2009-02-26 |
2020-08-03 |
Relmada Therapeutics Inc |
Orale farmaceutiske sammensætninger af 3-hydroxy-n-methylmorphinan med forlænget frigivelse og fremgangsmåde til anvendelse
|
|
AU2010223323B2
(en)
|
2009-03-10 |
2013-07-04 |
Euro-Celtique S.A. |
Immediate release pharmaceutical compositions comprising oxycodone and naloxone
|
|
CA2758571A1
(en)
|
2009-04-24 |
2010-10-28 |
Tissuetech, Inc. |
Compositions containing hc-ha complex and methods of use thereof
|
|
US8956654B2
(en)
|
2009-06-02 |
2015-02-17 |
Dow Global Technologies Llc |
Sustained release dosage form
|
|
US7718662B1
(en)
|
2009-10-12 |
2010-05-18 |
Pharmacyclics, Inc. |
Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase
|
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
|
CN102740830A
(zh)
*
|
2009-12-23 |
2012-10-17 |
普西维达公司 |
缓释递送装置
|
|
WO2013022801A1
(en)
|
2011-08-05 |
2013-02-14 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
|
WO2011097594A2
(en)
|
2010-02-08 |
2011-08-11 |
Kinagen, Inc. |
Therapeutic methods and compositions involving allosteric kinase inhibition
|
|
CN102884060B
(zh)
|
2010-03-24 |
2019-07-19 |
阿米泰克治疗方案公司 |
用于抑制激酶的杂环化合物
|
|
ES2665467T3
(es)
|
2010-03-29 |
2018-04-25 |
Astellas Pharma Inc. |
Composición farmacéutica de liberación modificada
|
|
KR20130073893A
(ko)
|
2010-04-13 |
2013-07-03 |
나지브 바불 |
1-메틸-2''-6''-피페콜옥실리디드의 피부 약제학적 조성물 및 사용 방법
|
|
ES2602475T3
(es)
|
2010-04-15 |
2017-02-21 |
Tracon Pharmaceuticals, Inc. |
Potenciación de la actividad anticáncer por terapia de combinación con inhibidores de la vía BER
|
|
CA2797533A1
(en)
|
2010-04-27 |
2011-11-10 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
EP2563776B1
(en)
|
2010-04-27 |
2016-06-08 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
ES2688072T3
(es)
|
2010-05-11 |
2018-10-30 |
Mallinckrodt Ard Ip Limited |
ACTH para el tratamiento de la esclerosis lateral amiotrófica
|
|
NZ736048A
(en)
|
2010-06-03 |
2019-09-27 |
Pharmacyclics Llc |
The use of inhibitors of bruton’s tyrosine kinase (btk)
|
|
JP6005636B2
(ja)
|
2010-07-06 |
2016-10-12 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
Ｇａｂａ類似体及びオピオイドを含む新規胃内滞留型剤形
|
|
AR082167A1
(es)
|
2010-07-14 |
2012-11-14 |
Gruenenthal Gmbh |
Formas de dosificacion gastrorretentivas
|
|
SG187730A1
(en)
|
2010-08-05 |
2013-03-28 |
Forsight Vision 4 Inc |
Injector apparatus and method for drug delivery
|
|
CN103153316B
(zh)
|
2010-08-05 |
2015-08-19 |
弗赛特影像4股份有限公司 |
组合药物递送方法和设备
|
|
RS62540B1
(sr)
|
2010-08-05 |
2021-12-31 |
Forsight Vision4 Inc |
Aparat za lečenje oka
|
|
MX337711B
(es)
|
2010-08-27 |
2016-03-15 |
Calcimedica Inc |
Compuestos que modulan el calcio intracelular.
|
|
US8796416B1
(en)
|
2010-10-25 |
2014-08-05 |
Questcor Pharmaceuticals, Inc |
ACTH prophylactic treatment of renal disorders
|
|
WO2012068549A2
(en)
|
2010-11-19 |
2012-05-24 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
|
CA2822790C
(en)
|
2010-12-22 |
2018-11-20 |
Purdue Pharma L.P. |
Encased tamper resistant controlled release dosage forms
|
|
PH12013501345A1
(en)
|
2010-12-23 |
2022-10-24 |
Purdue Pharma Lp |
Tamper resistant solid oral dosage forms
|
|
MY175521A
(en)
|
2011-01-07 |
2020-07-01 |
Allergan Inc |
Melanin modification compositions and methods of use
|
|
US9526770B2
(en)
|
2011-04-28 |
2016-12-27 |
Tissuetech, Inc. |
Methods of modulating bone remodeling
|
|
US9682044B2
(en)
|
2011-06-10 |
2017-06-20 |
Tissuetech, Inc. |
Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
|
|
US10398592B2
(en)
|
2011-06-28 |
2019-09-03 |
Forsight Vision4, Inc. |
Diagnostic methods and apparatus
|
|
RS61758B1
(sr)
|
2011-09-16 |
2021-05-31 |
Forsight Vision4 Inc |
Aparati za razmenu tečnosti
|
|
US20130090633A1
(en)
*
|
2011-10-07 |
2013-04-11 |
University Of Southern California |
Osmotic patch pump
|
|
CA2795586A1
(en)
|
2011-11-15 |
2013-05-15 |
Golden Biotechnology Corporation |
Methods and compositions for treatment, modification and management of bone cancer pain
|
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
|
CA2800329A1
(en)
|
2011-12-30 |
2013-06-30 |
Golden Biotechnology Corporation |
Methods and compositions for treating diabetes
|
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
|
FR2987264A1
(fr)
|
2012-02-23 |
2013-08-30 |
Golden Biotechnology Corp |
Methodes et compositions pour le traitement des metastases cancereuses
|
|
ES2886345T3
(es)
|
2012-03-26 |
2021-12-17 |
Golden Biotechnology Corp |
Métodos y composiciones para el tratamiento de enfermedades vasculares arterioescleróticas
|
|
ES2846789T3
(es)
|
2012-07-11 |
2021-07-29 |
Tissuetech Inc |
Composiciones que contienen complejos HC-HA/PTX3 y métodos de uso de los mismos
|
|
ES2647949T3
(es)
|
2012-07-16 |
2017-12-27 |
Rhodes Technologies |
Proceso para la síntesis mejorada de opioides
|
|
JP6236446B2
(ja)
|
2012-07-16 |
2017-11-22 |
ローズ テクノロジーズ |
改善されたオピオイド合成方法
|
|
US9512116B2
(en)
|
2012-10-12 |
2016-12-06 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
WO2014081675A1
(en)
|
2012-11-21 |
2014-05-30 |
Golden Biotechnology Corporation |
Methods and compositions for treating neurodegenerative diseases
|
|
WO2014123899A1
(en)
|
2013-02-05 |
2014-08-14 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
|
TWI597061B
(zh)
|
2013-02-20 |
2017-09-01 |
國鼎生物科技股份有限公司 |
治療白血病之方法及組成物
|
|
US10232018B2
(en)
|
2013-03-14 |
2019-03-19 |
Mallinckrodt Ard Ip Limited |
ACTH for treatment of acute respiratory distress syndrome
|
|
US9968603B2
(en)
|
2013-03-14 |
2018-05-15 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
|
AU2014233453A1
(en)
|
2013-03-15 |
2015-10-01 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
|
EP4302736A3
(en)
|
2013-03-28 |
2024-04-03 |
ForSight Vision4, Inc. |
Ophthalmic implant for delivering therapeutic substances
|
|
EP2991680A1
(en)
|
2013-04-30 |
2016-03-09 |
AbbVie Inc. |
Methods for improving lipid profiles using atrasentan
|
|
NZ716267A
(en)
|
2013-07-23 |
2017-05-26 |
Euro Celtique Sa |
A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
|
|
US10987313B2
(en)
|
2013-10-07 |
2021-04-27 |
Impax Laboratories, Llc |
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
|
|
EP3782614A1
(en)
|
2013-10-07 |
2021-02-24 |
Impax Laboratories, LLC |
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
|
|
US9611263B2
(en)
|
2013-10-08 |
2017-04-04 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
|
KR20160093675A
(ko)
|
2013-12-05 |
2016-08-08 |
파마싸이클릭스 엘엘씨 |
브루톤 티로신 키나제의 억제제
|
|
TWI546074B
(zh)
|
2014-01-15 |
2016-08-21 |
羅德科技公司 |
改良之羥考酮合成方法
|
|
AU2015207734B2
(en)
|
2014-01-15 |
2017-02-23 |
Rhodes Technologies |
Process for improved oxymorphone synthesis
|
|
ES2762806T3
(es)
|
2014-02-10 |
2020-05-25 |
Respivant Sciences Gmbh |
Tratamiento utilizando estabilizadores de mastocitos para trastornos sistémicos
|
|
DK3104854T3
(da)
|
2014-02-10 |
2020-05-04 |
Respivant Sciences Gmbh |
Mast-celle-stabilisatorer til lungesygdomsbehandling
|
|
WO2015164213A1
(en)
|
2014-04-23 |
2015-10-29 |
The Research Foundation For The State University Of New York |
A rapid and efficient bioorthogonal ligation reaction and boron-containing heterocycles useful in conjuction therewith
|
|
TW201603818A
(zh)
|
2014-06-03 |
2016-02-01 |
組織科技股份有限公司 |
組成物及方法
|
|
BR112017000774B1
(pt)
|
2014-07-15 |
2021-12-14 |
Forsight Vision4, Inc |
Sistema de manipulação de implante ocular
|
|
SG11201700943TA
(en)
|
2014-08-08 |
2017-03-30 |
Forsight Vision4 Inc |
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
|
|
US9839644B2
(en)
|
2014-09-09 |
2017-12-12 |
ARKAY Therapeutics, LLC |
Formulations and methods for treatment of metabolic syndrome
|
|
JP7037360B2
(ja)
|
2014-11-10 |
2022-03-16 |
フォーサイト・ビジョン フォー・インコーポレーテッド |
拡張可能な薬物送達デバイス
|
|
US9359316B1
(en)
|
2014-11-25 |
2016-06-07 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
|
US10227333B2
(en)
|
2015-02-11 |
2019-03-12 |
Curtana Pharmaceuticals, Inc. |
Inhibition of OLIG2 activity
|
|
BR112017017729A2
(pt)
|
2015-02-20 |
2018-04-10 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
forma de dosagem oral de liberação controlada de agonista de receptor gaba
|
|
TW201642914A
(zh)
|
2015-02-23 |
2016-12-16 |
組織科技股份有限公司 |
用於治療眼部疾病及失調的裝置及方法
|
|
EP3061501A1
(en)
|
2015-02-27 |
2016-08-31 |
Rottapharm Ltd. |
Composition for the treatment of acne
|
|
SG11201706989SA
(en)
|
2015-02-27 |
2017-09-28 |
Curtana Pharmaceuticals Inc |
Inhibition of olig2 activity
|
|
CA2984443A1
(en)
|
2015-05-20 |
2016-11-24 |
Tissuetech, Inc. |
Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
|
|
EP3117825A1
(en)
|
2015-07-16 |
2017-01-18 |
Rottapharm S.p.A. |
Oral formulation comprising berberine and morus alba extract
|
|
WO2017027402A1
(en)
|
2015-08-07 |
2017-02-16 |
Patara Pharma, LLC |
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
|
|
WO2017027387A1
(en)
|
2015-08-07 |
2017-02-16 |
Patara Pharma, LLC |
Methods for the treatment of mast cell related disorders with mast cell stabilizers
|
|
US20170209462A1
(en)
|
2015-08-31 |
2017-07-27 |
Pharmacyclics Llc |
Btk inhibitor combinations for treating multiple myeloma
|
|
CN113069681B
(zh)
|
2015-11-20 |
2022-12-23 |
弗赛特影像4股份有限公司 |
制造用于缓释药物递送的治疗装置的方法
|
|
CN115006537A
(zh)
|
2016-01-26 |
2022-09-06 |
利维申制药有限公司 |
α-肾上腺素能药剂的组合物和用途
|
|
TW201733600A
(zh)
|
2016-01-29 |
2017-10-01 |
帝聖工業公司 |
胎兒扶持組織物及使用方法
|
|
WO2017147146A1
(en)
|
2016-02-23 |
2017-08-31 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic trpv1 agonists
|
|
WO2017176886A1
(en)
|
2016-04-05 |
2017-10-12 |
Forsight Vision4, Inc. |
Implantable ocular drug delivery devices
|
|
AU2017263574B2
(en)
|
2016-05-12 |
2022-11-17 |
The Regents Of The University Of Michigan |
ASH1L inhibitors and methods of treatment therewith
|
|
US10821105B2
(en)
|
2016-05-25 |
2020-11-03 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists in combination with local anesthetics and vasoconstrictors for improved local anesthesia
|
|
WO2017205762A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
|
WO2017205766A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
|
WO2017205769A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
|
CA3028450A1
(en)
|
2016-07-06 |
2018-01-11 |
Durect Corporation |
Oral dosage form with drug composition, barrier layer and drug layer
|
|
CN106317468A
(zh)
*
|
2016-08-23 |
2017-01-11 |
无锡市永亿精密铸造有限公司 |
一种用于超声波美容仪的复合材料
|
|
EA201990508A1
(ru)
|
2016-08-26 |
2019-09-30 |
Куртана Фармасьютикалс, Инк. |
ИНГИБИРОВАНИЕ АКТИВНОСТИ Olig2
|
|
WO2018044942A1
(en)
|
2016-08-31 |
2018-03-08 |
Patara Pharma, LLC |
Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
|
|
US10736905B1
(en)
|
2016-09-09 |
2020-08-11 |
Shahin Fatholahi |
Nefopam dosage forms and methods of treatment
|
|
JP2019531308A
(ja)
|
2016-10-07 |
2019-10-31 |
レシュピファント サイエンシス ゲゼルシャフト ミット ベシュレンクター ハフトゥングＲｅｓｐｉｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ |
肺線維症の治療のためのクロモリン組成物
|
|
US11446311B2
(en)
|
2017-09-08 |
2022-09-20 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
|
US10736874B1
(en)
|
2017-09-08 |
2020-08-11 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
|
CA3082086A1
(en)
|
2017-11-10 |
2019-05-16 |
The Regents Of The University Of Michigan |
Ash1l inhibitors and methods of treatment therewith
|
|
AU2018372806B2
(en)
|
2017-11-21 |
2024-05-30 |
Forsight Vision4, Inc. |
Fluid exchange apparatus for expandable port delivery system and methods of use
|
|
JP7414282B2
(ja)
|
2017-12-07 |
2024-01-16 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
Ｎｓｄファミリー阻害物質及びそれによる治療の方法
|
|
US10213393B1
(en)
|
2018-02-15 |
2019-02-26 |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Feleõsségû Társaság |
Composition and method for treating neurological disease
|
|
US20190247331A1
(en)
|
2018-02-15 |
2019-08-15 |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság |
Composition and method for treating neurological disease
|
|
US10213394B1
(en)
|
2018-02-15 |
2019-02-26 |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság |
Composition and method for treating neurological disease
|
|
MX2020008527A
(es)
|
2018-02-16 |
2020-09-18 |
Esperion Therapeutics Inc |
Formulaciones de liberacion sostenida de acido bempedoico.
|
|
WO2019169112A1
(en)
|
2018-02-28 |
2019-09-06 |
Curtana Pharmaceuticals, Inc. |
Inhibition of olig2 activity
|
|
EP3813784B1
(en)
|
2018-06-07 |
2024-01-10 |
The Regents Of The University Of Michigan |
Prc1 inhibitors and prc1 inhibitors for use in methods of treatment therewith
|
|
EP3830078A4
(en)
|
2018-07-27 |
2022-03-30 |
Concentric Analgesics, Inc. |
PEGYLATED PRODRUGS OF PHENOLIC TRPV1 AGONISTS
|
|
BR112021011578A2
(pt)
|
2018-12-31 |
2021-08-31 |
Biomea Fusion, Llc |
Inibidores irreversíveis de interação menina-mll
|
|
US12377082B2
(en)
|
2019-03-15 |
2025-08-05 |
Unicycive Therapeutics Inc. |
Nicorandil derivatives
|
|
CN115697313A
(zh)
|
2020-05-08 |
2023-02-03 |
国鼎生物科技股份有限公司 |
用于治疗rna病毒诱导的疾病的方法和组合物
|
|
AU2021304826A1
(en)
|
2020-07-10 |
2023-02-02 |
The Regents Of The University Of Michigan |
GAS41 inhibitors and methods of use thereof
|
|
CA3202151A1
(en)
|
2020-12-16 |
2022-06-23 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin-mll interaction
|
|
US11986449B2
(en)
|
2020-12-22 |
2024-05-21 |
Amneal Pharmaceuticals Llc |
Levodopa dosing regimen
|
|
JP2024501235A
(ja)
|
2020-12-22 |
2024-01-11 |
アムニール ファーマスーティカルズ エルエルシー |
レボドパ投薬レジメン
|
|
JP2024531170A
(ja)
|
2021-08-11 |
2024-08-29 |
バイオメア フュージョン，インコーポレイテッド |
真性糖尿病に対するメニン－ｍｌｌ相互作用の共有結合性阻害剤
|
|
WO2023027966A1
(en)
|
2021-08-24 |
2023-03-02 |
Biomea Fusion, Inc. |
Pyrazine compounds as irreversible inhibitors of flt3
|
|
US20240409558A1
(en)
|
2021-09-13 |
2024-12-12 |
Biomea Fusion, Inc. |
Irreversible inhibitors of kras
|
|
US20250066386A1
(en)
|
2021-11-09 |
2025-02-27 |
Biomea Fusion, Inc. |
Inhibitors of kras
|
|
WO2023119230A1
(en)
|
2021-12-22 |
2023-06-29 |
L'oreal |
Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
|
|
AU2022426699A1
(en)
|
2021-12-30 |
2024-07-11 |
Biomea Fusion, Inc. |
Pyrazine compounds as inhibitors of flt3
|
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
|
WO2023235618A1
(en)
|
2022-06-03 |
2023-12-07 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin
|
|
WO2024243402A2
(en)
|
2023-05-24 |
2024-11-28 |
Unicycive Therapeutics Inc. |
Salt forms of nicorandil derivatives
|
|
WO2024249950A1
(en)
|
2023-06-02 |
2024-12-05 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin
|
|
WO2025034784A1
(en)
|
2023-08-08 |
2025-02-13 |
United Therapeutics Corporation |
A method of producing an oral osmotic pharmaceutical delivery system and a pharmaceutical batch produced using the same
|
|
US20250145571A1
(en)
|
2023-09-26 |
2025-05-08 |
Unicycive Therapeutics, Inc. |
Amino acid prodrugs of nicorandil
|